Member Info for liquid1

This was posted on the French website when NCYT was 25c in France: Wish I had stayed with CYT. St was volatile as it her on RMS. Let's see we we are in 2 weeks time, December !

"Novacyt is the only one to develop a test to detect Corona virus"

Novacyt rises 81%

The Novacyt share shot up on Friday, January 31, after the company announced it had developed a test to detect the Corona virus. The test, called genesig® 2019-nCoV, is now for sale and orders are coming in. According to the first reports, tens of thousands of tests have already been sold in around 10 countries. The rate can rise much further than where it is now is our expectation. The share of the France company increased no less than 81% from 0.25 euros to 0.45 euros. After Friday's price rise, the market value is 26.2 million euros. That is only a small amount based on the potential revenue growth that can be expected from the sale of the Corona virus tests.

Genesig® 2019-nCoV

The genesig® 2019-nCoV is the first test in the world developed to detect the Corona virus. That is why the company currently has a huge gold mine. There are two different tests for sale, one cost converted to euros per package (150 pieces) around 300 euros and the other per package (150 pieces) 700 euros. The latter test can determine within two hours whether someone is wearing the Corona virus. The Corona virus, which originally started in China, has since spread to several countries.

Turnover can be tenfold

The question is how many tests the company will take. That is of course very difficult to determine and will depend on how long and how far the virus continues to spread. Suppose the company is going to sell 100,000 tests worldwide, that gives a turnover of around 40 million euros. The stock market value after the price rise last Friday is 26.2 million euros. There are currently 57 million shares outstanding. The turnover for 2019 was 13 million euros. Suppose that the result is repeated with the sale of the test, then the turnover for 2020 will be around € 53 million. Suppose the virus continues to expand, we estimate that the test will be sold more than a million times. The turnover would then be tenfold and yield 400 million euros.

Price target 7 euros

Again, it is guessing about the actual sale of the Novacyt tests. Nevertheless, the enormous demand for the product provides enough certainty to expect a turnover explosion for 2020. In a negative scenario, the total turnover can amount to 53 million euros. In a positive scenario, sales will amount to 450 million euros. If we look at Novacyt's average valuation over the past 10 years, the rate could rise to between 1 euro and 7 euros. In the first case, that means a price potential based on Friday's closing price of 110%. In the second scenario, the rate can even rise by 1500%. The news about the Corona virus will hold the share in its grip in the coming days and we expect the price to rise further next week.

htTps://www.po

DG1 Investo

Thanks for the clarification!

Have good day.

Pharm2Farm
@Pharm2Farm_org
·
15h
One of the novel steps we’ve incorporated is to bind the two filter layers directly onto the surface of the inner and outer layers, so to the naked eye they are one layer each. We’ve also added the pigment to the filter layer to reduce any posable allergic reactions to dye.
Pharm2Farm
@Pharm2Farm_org
·
15h
Whereas the inner most layer is a hypoallergenic hydrophilic spunbonded polypropylene layer, designed to feel comfortable on the face and highly breathable. #innovation #SecondLockdown
Pharm2Farm
@Pharm2Farm_org
·
15h
The result is that the mask has a bacterial filtration efficiency (BFE) of >99.98%. The outer most layer is a hydrophobic spunbonded polypropylene fabric that repels moisture and bodily fluids. #facemask #covid19
Pharm2Farm
@Pharm2Farm_org
·
15h
P2F’s masks adopt the same non-woven melt blown polypropylene barrier technology that is incorporated into current state of the art fluid-resistant Type IIR surgical mask; however, we have incorporated two of these layers rather than just one. #facemask
Pharm2Farm
@Pharm2Farm_org
·
Nov 12
Pharm2Farm's Antiviral face mask!!

Pharm2Farm
@Pharm2Farm_org
·
15h
The inner layer is the antiviral one and contains our patented copper nanoparticle formulation that has been printed and melted onto the fabric, enough for it not to fall away but not completely engulfed so it retains its active surface. #covid19 #facemask #secondwave

Pharm2Farm
@Pharm2Farm_org
·
15h
Our nanoparticles are spherical in appearance, this results in a large surface area to volume ratio. This increase in effective surface area and the fact that the nanoparticles are in the same size domain as the virus (~100 nm) results in a highly efficient virucide. #nano

Pharm2Farm
@Pharm2Farm_org
·
15h
In the absence of the antiviral layer any filter can end up concentrating up pathogens in the mask; as is the case with other Type IIR masks. If the filter, then gets compromised you could end up inhaling or exhaling a large concentration the very thing you are trying to stop.

Pharm2Farm
@Pharm2Farm_org
·
15h
Pharm2Farm deliberately targeted the Type IIR surgical mask first as they are what professional healthcare users use and extremely scalable to produce at a price point that is accessible to everyone - unlike other masks and coverings that claim to be anti-COVID-19 on the market.

Pharm2Farm
@Pharm2Farm_org
Other face “coverings” on the market that proclaimed to kill viruses, including those with embedded copper, don’t have a filter that is small enough (<100nm) to prevent the virus or the cells, that carry it, from passing through. #facemask #SecondLockdown #covid19

https://twitter.com/Pharm2Farm_org/status/1327648092460617729?s=20

Is this officially from Trevor Brown?????

“We think BBC is 11 am Monday and itv is 12:30 Monday. We are assuming they will go out on East Midlands and Central News broadcasts throughout the afternoon and evening. However links should also be available. Of course it is the nature of news that some unexpected major national or international event could 'bump' these interviews into the next day or even late“

Due to large customer interest we have produced the datasheet below. It is a draft and subject to change. The mask products will be sold once certification is complete. Pre-orders can be placed on the shop page

https://www.pharm2farm.org/face-masks/

Braveheart Inv Group
Final Results
RNS Number : 9977U
Braveheart Investment Group plc
04 August 2020

Pharm2Farm Limited (P2F)

Early stage proof of principle trials to integrate P2F's nanoparticle technology into face mask material have been successful. As a result, P2F's anti-viral face mask project is on schedule to produce a pre-commercial prototype anti-viral face mask on their UK their production line by November 2020.

If successful, P2F will seek both to manufacture disposable face masks in-house and to licence its technology to major face mask producers, in order to supply a global market which generated global revenues of $1.52 billion in 2019 and is estimated to reach $2.45 billion by 2027, registering a compound annual growth rate (CAGR) of 4.4% from 2021 to 2027 (Source: Allied Market Research report May 2020)

https://www.investegate.co.uk/braveheart-inv-group--brh-/rns/final-results/202008040700029977U/

Let’s get to 10p first!

100p is too far away....

Crying out to interview Gareth
hTTps://twitter.com/share_talk/status/1327304262305648641?s=21

Crying out to interview Gareth
hTTps://twitter.com/share_talk/status/1327304262305648641?s=21

The project will combine P2F's nanoparticle manufacturing capabilities with filter materials, which are also nanotechnology based, made by its partner. Early stage proof of principle trials to integrate P2F's nanoparticle technology into face mask material have been successful. As a result, P2F's anti-viral face mask project is on schedule to produce a pre-commercial prototype anti-viral face mask on their UK their production line by November 2020.

If successful, P2F will seek both to manufacture disposable face masks in-house and to licence its technology to major face mask producers, in order to supply a global market which generated global revenues of $1.52 billion in 2019 and is estimated to reach $2.45 billion by 2027, registering a compound annual growth rate (CAGR) of 4.4% from 2021 to 2027 (Source: Allied Market Research report May 2020).

https://www.investegate.co.uk/braveheart-inv-group--brh-/rns/final-results/202008040700029977U/

Gareth Cave
@GarethCave
·
35m
The Uk demand is about 2million a day, so we’re “gonna need a bigger boat”. Lots of things in the pipeline so keep an eye out on the rns next week.

https://twitter.com/GarethCave/status/1327253657767784456?s=20

Gareth Cave
@GarethCave
·
1h
Interview with the East Midlands’ Capital FM and Smooth Radio guys this afternoon. If you are local tune in!
Gareth Cave
@GarethCave
·
7m
Jaut finished the interview with these guys. Not sure when it will be aired but will share the link when it does.

Five-layer surgical face mask embedded with antiviral copper 'kills 90% of coronavirus particles' and will be available to British doctors by CHRISTMAS

By Joe Pinkstone For Mailonline
15:13, 12 Nov 2020 , updated 15:13, 12 Nov 2020

https://www.dailymail.co.uk/sciencetech/article-8942329/Face-mask-copper-kills-90-coronavirus-available-doctors-CHRISTMAS.html?ito=social-twitter_dailymailUK

Copper has long been heralded for its anti-viral properties, with experts calling for it to be used on shopping trolleys and door knobs to halt transmission.

Dr Felicity de Cogan of the University of Birmingham said in June that copper has shown promise when it comes to killing the virus, meaning that people who touch these surfaces are unlikely to pick it up on their hands.

She says studies have found that even non-engineered metal is 99 per cent effective at killing the virus after 2-6 hours.

It is well known that copper has inherent antimicrobial properties, but Dr de Cogan said the time-frame that it does this in is insufficient at preventing the spread of coronavirus in the community.

Nottingham's Dr Cave used his expertise with nanotechnology to supercharge the antiviral properties of copper.

Description
This product is available to pre-order pending certification. No monies will be payable until full certification is achieved.

Prices are for shipping within the UK only.